Lazard Asset Management »

Cogent Biosciences shares owned by Lazard Asset Management

Quarter-by-quarter ownership of Cogent Biosciences shares owned by Lazard Asset Management from 13F filings

Historical chart of Lazard Asset Management investment in Cogent Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Cogent Biosciences held by Lazard Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cogent Biosciences by Lazard Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $6.2k 506k 0.01

More positions owned by Lazard Asset Management

Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
American Tower Reit (AMT)
Exelon Corporation (EXC)
Crown Castle Intl (CCI)
Alphabet Cap Stk Cl A (GOOGL)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Alphabet Cap Stk Cl C (GOOG)
Canadian Natl Ry (CNI)
Broadcom (AVGO)
Ferrovial Se Ord Shs (FER)
Consolidated Edison (ED)
CSX Corporation (CSX)

View all positions for Lazard Asset Management

Top funds holding Cogent Biosciences

Linden Advisors
Wolverine Asset Management
Calamos Advisors
Oaktree Capital Management
Lord, Abbett & Co
Jump Financial
Ameriprise Financial
Polar Capital Holdings
Wellesley Investment Advisors
Advent Capital Management
SSI Investment Management
Henderson Group
Leucadia National Corporation
Millennium Management
Ares Systematic Credit

View all funds holding Cogent Biosciences